Items where Author is "Popplewell, L"

Up a level
Export as [feed] Atom [feed] RSS
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 4.

Article

Harish, P and Malerba, A and Lu-Nguyen, N and Forrest, L and Cappellari, O and Roth, F and Trollet, C and Popplewell, L and Dickson, G (2019) Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD). Journal of Cachexia, Sarcopenia and Muscle.

Koo, T and Lu-Nguyen, N B and Malerba, A and Kim, E and Kim, D and Cappellari, O and Cho, H-Y and Dickson, G and Popplewell, L and Kim, J-S (2018) Functional rescue of dystrophin deficiency in mice caused by frameshift mutations using Campylobacter jejuni Cas9. Molecular Therapy.

Malerba, A and Graham, I and Sharp, P and Popplewell, L and Foster, K and Wells, D J and Dickson, G (2011) Chronic Systemic Therapy With Low-dose Morpholino Oligomers Ameliorates the Pathology and Normalizes Locomotor Behavior in mdx Mice. Molecular Therapy, 19 (2). pp. 345-54.

Kinali, M and Arechavala-Gomeza, V and Feng, L and Cirak, S and Hunt, D and Adkin, C and Guglieri, M and Ashton, E and Abbs, S and Nihoyannopoulos, P and Garralda, M E and Rutherford, M and McCulley, C and Popplewell, L and Graham, I R and Dickson, G and Wood, M J and Wells, D J and Wilton, S D and Kole, R and Staub, V and Bushby, K and Sewry, C and Morgan, J E and Muntoni, F (2009) Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-esclation, proof-of-concept study. Lancet Neurology, 8 (10). pp. 918-28.

This list was generated on Fri May 14 07:35:46 2021 BST.